glp 1 development history Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists: A State-of-the-Art Narrative Review | Drugs The transformative breakthroughs in GLP-1

This not only increases hypoglycemia risk but may also reduce patient confidence in their treatment plan

These adverse effects can be mitigated or reduced by slowly escalating the dosewhich is exactly what's in the package insertby keeping close contact with the patient, and [by not] dose escalating while they're still having adverse effects

Alpha-lipoic acid for diabetic peripheral neuropathy

Resilience, from complex systems' perspective, is defined as the ability to absorb disturbances before the system shifts to a different state and the capacity for self-(re)organization and adaptation (Mochizuki et al., 2018)

Pharmacological intervention targeting FAF1 restores autophagic flux for -synuclein degradation in the brain of a Parkinsons disease mouse model